Allergy and infectious diseases research in Colorado

Colorado crossed with CFDA 93.855

CFDA 93.855 is titled ALLERGY AND INFECTIOUS DISEASES RESEARCH. Crossed with Colorado place of performance, obligations sum to $475,768,789.60 on 339 awards. The national 93.855 hub includes other states. Colorado’s spending hub includes other programs. Only this intersection is reported here. $475,768,789.60 is an obligation aggregate from USAspending.gov, not an outlay and not a count of labs in Denver or Boulder.

Three hundred thirty-nine awards is a multi-project extramural pattern: NIAID assistance often posts as hundreds of discrete records rather than one statewide block. The join does not name recipients. Packet facts are $475,768,789.60, 339 awards, CO, and 93.855. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep NIAID research and Colorado together when reading $475,768,789.60.

93.855 is not a CDC investigation catalog in Colorado

CDC investigation catalogs use different CFDA numbers. Mixing those series into $475,768,789.60 would invent a broader total than this cell contains. Facts available: Colorado, CFDA 93.855, $475,768,789.60, 339 awards. Study titles, activity codes, and publication counts are unpublished.

The catalog title names allergy and infectious diseases research, not a ranking of academic medical centers. Dividing $475,768,789.60 by 339 yields about $1.40 million per award. Unique recipients are unpublished. 339 is not a lab or PI census.

Place of performance on the NIAID tag

CO is the place-of-performance code. Awards billed to Denver, Boulder, Fort Collins, or other in-state sites can share the tag. Awards coded to Wyoming, Nebraska, Kansas, Oklahoma, New Mexico, Utah, or Arizona stay outside $475,768,789.60 even when activity later crosses those lines. The code does not convert $475.77 million into a campus map.

Colorado federal spending is the all-program parent. 93.855 is one row on Colorado programs. $475.77 million is not the state’s complete federal footprint. Open Allergy And Infectious Diseases Research in Colorado for the filtered table, CFDA 93.855 for the catalog without a Colorado filter, and All spending ties for other pairs. Do not add those parents into $475,768,789.60.

Reading 339 awards under $475.77 million

$475,768,789.60 ÷ 339 is about $1.40 million per award. That average is an extramural-project scale, not a per-patient cost, not a median. Net obligations can include downward modifications; the total shown is the aggregate in the facts. Treat 339 as a record count, not as 339 finished trials.

Without a transaction register, you cannot see how many of the 339 rows are continuations, renewals, or corrections. Later ingests can restate $475,768,789.60 without changing the join key of 93.855 and CO. USAspending obligations can be positive new awards or net of downward modifications; $475,768,789.60 is the net total supplied in the facts. The pair remains NIAID research plus Colorado. Do not treat $475,768,789.60 as an outlay series.

What the NIAID–Colorado pair does not prove

A large 93.855 total tagged to Colorado does not measure whether incidence fell, and it does not equal papers published. FEC donations do not fund this USAspending cell. Correlation is not causation. The headline remains $475,768,789.60 on 339 awards for NIAID research in Colorado.

Keep both sides of the join: Allergy And Infectious Diseases Research and Colorado, obligations only. Do not annualize $475,768,789.60 without a year field—this packet publishes none. Do not treat 339 as a lab or PI census. Quote USAspending.gov and the overlay path rather than an outbreak story. Cite NIAID research together with Colorado whenever you reuse $475,768,789.60.

Using the 93.855–Colorado overlay

The overlay target is the Colorado × CFDA 93.855 table. Open Allergy And Infectious Diseases Research in Colorado when you want the same $475,768,789.60 / 339-award cell in the site’s data chrome. CFDA 93.855 drops the Colorado filter. Colorado federal spending drops the CFDA filter. Colorado programs lists other catalogs beside 93.855. All spending ties indexes other pairs.

This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that Colorado won or lost federal money, that donations paid for the awards, or that obligations equal cash. The pair is 93.855 plus CO. Obligations of $475,768,789.60 are not outlays. Original filings remain on USAspending.gov for this 93.855 × CO pair. 339 remains an award-record count, not a person, facility, or project census.

Questions

How much NIAID research is obligated in Colorado?

USAspending records $475,768,789.60 in CFDA 93.855 obligations with Colorado place of performance on 339 awards. That is the pair total, not an outlay. Keep Allergy And Infectious Diseases Research and Colorado together when citing $475,768,789.60.

Does 339 awards mean 339 Colorado laboratories?

339 is a USAspending award-record count, not a lab or PI census. The implied mean is about $1.40 million per award. Unique recipients are unpublished. 339 is a record count, not a person or facility census.

Is this Colorado’s total federal research spending?

No. This join is CFDA 93.855 only. Other NIH institute catalogs appear on separate Colorado program pages. Nationwide 93.855 is not limited to Colorado. Obligations of $475,768,789.60 are not outlays. The overlay is the live NIAID research–Colorado table.

Do these obligations equal research completed?

No. $475,768,789.60 is an obligation sum. Outlays are a different USAspending series. Drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.855 × CO pair.